| Position | Action |
|---|---|
| Price at $322 zone | Trim 20-25% of existing TSLA exposure |
| Post-trim residual position | Retain 75-80% of original position for asymmetric participation |
| Price at or below $300 on residual | Hard stop triggered on residual exposure |
TSLA's 26% YTD decline has created a capitulation-driven entry point with exhaustion signals, fortress balance sheet ($43.5B cash), and $5.8B strategic capex cycle into AI/robotics optionality, all against a favorable macro backdrop.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 326.64 | bearish |
| 50 SMA | 388.86 | bearish |
| 200 SMA | 411.06 | bearish |
| RSI (14) | 36.83 | neutral |
| RSI Low (2026-07-29) | 25.42 | bullish |
| MACD | -24.71 | bearish |
| MACD Signal | -19.98 | bearish |
| MACD Histogram | -4.74 | bullish |
| Bollinger Middle (20 SMA) | 359.05 | bearish |
| Bollinger Upper | 441.88 | neutral |
| Bollinger Lower | 276.21 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
TSLA Underweight: Trim 20-25% at $322, retain 75-80% with $300 stop and put spread hedge
The Neutral analyst's 20-25% trim with $300 stop is the architecture most consistent with prior lessons: it acknowledges dominant bear evidence through directional reduction, preserves upside participation if the oversold bounce extends toward $359 (20 SMA), and anchors residual exposure to the Q3 catalyst window rather than the current fundamental snapshot. The aggressive analyst's BUY overreach is rejected—bear flag structure, 145x forward P/E, and FCF inflection all argue against front-running an unformed setup. The full SELL is rejected for the same reason prior Underweight calls stalled: it locks in defensive positioning at the wrong moment in the price path. Price target: $280 over 3-6 months, gated by Q3 revalidation catalysts.
When: Q3 data point validates FCF/margin decay narrative
Then: Consider further trim action
Forward valuation is more relevant than trailing P/E for a company in reinvestment mode
↩ rebuts: “Bear use of 295x trailing P/E as disqualifying factor”
· concedes: Trailing P/E of 295x is high in absolute terms; Q2 earnings disappointed; Q2 FCF turned negative at -$1.10B; Bear thesis anchored to backward-looking technical signals, trailing multiples, and one quarter of disappointing earnings; BYD export growth and Chinese EV pricing pressure are real competitive headwinds
Tesla is a $1.27 trillion company with an auto business breaking in real time, propped up by future promises the market is increasingly reluctant to underwrite; the technical structure confirms unfinished distribution, the fundamentals show margin collapse and negative free cash flow, and any slip in the AI thesis sends the stock to $270-280.
· concedes: Polymarket gives 68% odds of $330 this week (meaningful probability of upside near-term); ARK does buy dips in names they believe in (though TSLA allocation is tiny); Gross margins on EVs may partially recover if macro improves or cost cuts take effect; TSLA does have scale and brand that Rivian/Lucid don't; The $26M ARK purchase does signal some conviction, even if small
→ vs conservative: The conservative analyst is treating intelligent capital deployment like a balance sheet problem - treating $5.8B CapEx funded entirely from $43.5B internal cash (not debt, not dilution) as structural deterioration is lazy analysis
→ vs conservative: The SELL decision is a textbook case of letting recency bias and stale narratives destroy asymmetric upside; the 26% YTD decline has already fully priced in known competitive threats like BYD and Waymo
→ vs neutral: The HOLD position is fence-sitting anchored to the same flawed premise that the trend is the trend; after capitulation with oversold indicators, the job is to identify when the market is mispricing the next leg, not respect exhausted trends
| neutral |
| ATR (14) | 16.64 | bearish |
| Volume (2026-07-23 record) | 115606400 | bearish |
| Volume (2026-08-03) | 37160000 | bullish |
Support: 276.21 · 298.32 · 310.42 | Resistance: 326.64 · 359.05 · 388.86 · 411.06
TSLA exhibits a textbook bearish downtrend stack with price ($322.08) below all major moving averages: 10 EMA 326.64, 50 SMA 388.86, and 200 SMA 411.06. RSI recovered from a 25.42 oversold low (2026-07-29) to 36.83 but remains below the neutral 50 level, while MACD at -24.71 shows bearish momentum deceleration with histogram narrowing to -4.74. The 2026-08-03 reversal candle (open 311.01, close 322.08 on 37.2M shares) suggests a tentative bounce from the $298–$310 support zone, but lacks climactic volume for confirmation. Bollinger Bands have widened significantly (lower band at $276.21 vs prior $371.99), reflecting elevated volatility with ATR at 16.64. Short-sellers maintain the edge with trailing stops above $326.64, while tactical longs require price reclaiming $359 (20 SMA) with a flattening 50 SMA slope before initiating. Final transaction proposal: HOLD.
Market Cap
$1,272.07B
P/E (TTM)
295.49x
Forward P/E
145.13x
PEG Ratio
4.56
Price / Book
14.38x
EPS (TTM)
$1.09
Forward EPS
$2.22
Beta
1.827
52-Week High
$498.83
52-Week Low
$297.38
50-Day MA
$390.76
200-Day MA
$411.60
Revenue (TTM)
$103.62B
Gross Profit (TTM)
$19.53B
EBITDA (TTM)
$10.76B
Net Income (TTM)
$3.81B
Profit Margin (TTM)
3.67%
Operating Margin (TTM)
1.41%
ROE (TTM)
4.67%
ROA (TTM)
1.93%
Q2 2026 Revenue
$28.24B
Q2 2026 Gross Profit
$4.75B
Q2 2026 Net Income
$1,114M
Q2 2026 Diluted EPS
$0.32
Q2 2026 R&D
$2.37B
Q2 2026 SG&A
$1.98B
Q2 2026 Total OpEx
$4.35B
Q2 2026 Operating CF
$4.70B
Q2 2026 CapEx
-$5.80B
Q2 2026 FCF
-$1.10B
TTM FCF
$4.84B
Q2 2026 SBC
$1.15B
Q2 2026 Total Assets
$148.5B
Q2 2026 Cash & ST Investments
$43.52B
Q2 2026 Total Debt
$16.08B
Q2 2026 Total Equity
$86.86B
Q2 2026 Working Capital
$33.33B
Q2 2026 Current Ratio
1.94
Q2 2026 Inventory
$13.75B
Q2 2026 Net PPE
$62.40B
Net Cash Position
~$27.4B
Diluted Shares Outstanding
3.54B
Strengths
Concerns
Tesla presents a highly asymmetric risk/reward profile at current levels. The company is in deep strategic transition from an auto manufacturer with thin margins (3.67% profit margin, 1.41% operating margin) to an AI/robotics/energy enterprise, with the market capitalization reflecting bets on Cybercab/robotaxi, Optimus humanoid robot, and FSD autonomy rather than current earnings. The fortress balance sheet ($43.52B cash, $27.4B net cash) provides ample runway for aggressive reinvestment, but Q2 2026 marked the first negative FCF quarter in the visible period as capex surged to $5.80B — more than double the prior quarter — reflecting massive investment in robotaxi production lines, Megapack capacity, and Optimus infrastructure. Gross margin compression to 16.82% in Q2 2026 from 21.08% in Q1 2026 is a significant concern, while the valuation (295x P/E, 145x forward P/E, 4.56 PEG) offers virtually no margin of safety for execution delays in the AI/autonomy thesis.